DK1594520T3 - Anvendelse af antagonister af bradykinin B2 receptorer til behandling af osteoarthrosis - Google Patents

Anvendelse af antagonister af bradykinin B2 receptorer til behandling af osteoarthrosis

Info

Publication number
DK1594520T3
DK1594520T3 DK04704552T DK04704552T DK1594520T3 DK 1594520 T3 DK1594520 T3 DK 1594520T3 DK 04704552 T DK04704552 T DK 04704552T DK 04704552 T DK04704552 T DK 04704552T DK 1594520 T3 DK1594520 T3 DK 1594520T3
Authority
DK
Denmark
Prior art keywords
osteoarthrosis
bradykinin
antagonists
receptors
treatment
Prior art date
Application number
DK04704552T
Other languages
Danish (da)
English (en)
Inventor
Martin Michaelis
Karl Rudolphi
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1594520T3 publication Critical patent/DK1594520T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK04704552T 2003-02-07 2004-01-23 Anvendelse af antagonister af bradykinin B2 receptorer til behandling af osteoarthrosis DK1594520T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10304994A DE10304994A1 (de) 2003-02-07 2003-02-07 Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose

Publications (1)

Publication Number Publication Date
DK1594520T3 true DK1594520T3 (da) 2006-12-11

Family

ID=32797325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04704552T DK1594520T3 (da) 2003-02-07 2004-01-23 Anvendelse af antagonister af bradykinin B2 receptorer til behandling af osteoarthrosis

Country Status (31)

Country Link
EP (1) EP1594520B1 (ru)
JP (1) JP2006516980A (ru)
KR (1) KR20050105447A (ru)
CN (1) CN1317029C (ru)
AR (1) AR043036A1 (ru)
AT (1) ATE335500T1 (ru)
AU (1) AU2004210396A1 (ru)
BR (1) BRPI0407333A (ru)
CA (1) CA2514152C (ru)
CO (1) CO5690613A2 (ru)
CY (1) CY1105708T1 (ru)
DE (2) DE10304994A1 (ru)
DK (1) DK1594520T3 (ru)
ES (1) ES2268622T3 (ru)
HK (1) HK1085926A1 (ru)
HR (1) HRP20050701B1 (ru)
IL (1) IL169899A0 (ru)
MA (1) MA27618A1 (ru)
ME (1) MEP41008A (ru)
MX (1) MXPA05007310A (ru)
MY (1) MY135827A (ru)
NO (1) NO333903B1 (ru)
NZ (1) NZ541680A (ru)
PE (1) PE20040939A1 (ru)
PL (1) PL206412B1 (ru)
PT (1) PT1594520E (ru)
RS (1) RS51029B (ru)
RU (1) RU2329057C2 (ru)
TW (1) TW200505472A (ru)
WO (1) WO2004069266A2 (ru)
ZA (1) ZA200505177B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0710522D0 (en) * 2007-06-01 2007-07-11 Royal Veterinary College The Drug delivery system comprising matrix metalloproteinase inhibitors
IT1391236B1 (it) * 2008-07-11 2011-12-01 St Luso Farm D'italia Spa Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
FR2751650B1 (fr) * 1996-07-24 1998-10-09 Fournier Ind & Sante Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
CA2364178C (en) * 2000-12-05 2006-01-10 Yasuhiro Katsu N-benzenesulfonyl l-proline compounds as bradykinin antagonists
CA2474645C (en) * 2002-02-01 2011-08-09 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation

Also Published As

Publication number Publication date
NO333903B1 (no) 2013-10-14
AR043036A1 (es) 2005-07-13
HK1085926A1 (en) 2006-09-08
BRPI0407333A (pt) 2006-01-10
ZA200505177B (en) 2006-11-29
DE502004001159D1 (de) 2006-09-21
MA27618A1 (fr) 2005-11-01
RS20050565A (en) 2007-09-21
EP1594520A2 (de) 2005-11-16
ES2268622T3 (es) 2007-03-16
CN1747742A (zh) 2006-03-15
ATE335500T1 (de) 2006-09-15
CA2514152C (en) 2012-01-17
PL376605A1 (pl) 2006-01-09
CN1317029C (zh) 2007-05-23
TW200505472A (en) 2005-02-16
IL169899A0 (en) 2011-08-01
PL206412B1 (pl) 2010-08-31
CA2514152A1 (en) 2004-08-19
JP2006516980A (ja) 2006-07-13
AU2004210396A1 (en) 2004-08-19
NO20054144L (no) 2005-09-06
RU2005127862A (ru) 2006-01-27
DE10304994A1 (de) 2004-09-02
HRP20050701A2 (en) 2006-09-30
HRP20050701B1 (hr) 2014-01-03
WO2004069266A2 (de) 2004-08-19
MY135827A (en) 2008-07-31
CO5690613A2 (es) 2006-10-31
CY1105708T1 (el) 2010-12-22
MEP41008A (en) 2011-02-10
EP1594520B1 (de) 2006-08-09
WO2004069266A3 (de) 2004-09-30
PT1594520E (pt) 2006-11-30
MXPA05007310A (es) 2005-09-30
RS51029B (sr) 2010-10-31
PE20040939A1 (es) 2005-01-17
RU2329057C2 (ru) 2008-07-20
NZ541680A (en) 2009-07-31
KR20050105447A (ko) 2005-11-04

Similar Documents

Publication Publication Date Title
IS8501A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
DK1638969T3 (da) CGRP-receptorantagonister
DE602005012267D1 (de) N von geräten
DK1643998T3 (da) NK1/NK3-antagonister til behandling af skizofreni
DK3395339T3 (da) Hurtigt opløsende formulering af cinacalcet-hcl
IS7362A (is) Kínasólín efnasambönd
ATE461191T1 (de) N-substituierte 2-oxodihydropyridinderivate als npy antagonisten
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
IL175084A0 (en) Antagonists of the bradykinin b1 receptor
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1763520T3 (da) Anvendelse af trisubstituerede benzopyranoner
ATE397618T1 (de) Peptidcyclisierung
DE602004019555D1 (de) Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone
IS7833A (is) Efnasambönd með sameinaða heteróhringi
DE602005001661D1 (de) Vermessungsgerät
DE602004000143D1 (de) Schwingungsgyroskop
ATE469875T1 (de) Nk1-antagonisten
DK1727801T3 (da) Til behandling af smerter anvendelige piperaziner
IS8278A (is) Sýkóprópýl afleiður sem NK3 viðtaka mótlyf
DE602004030875D1 (de) Duschkopf
DK1660485T3 (da) Forbedret fremgangsmåde til fremstilling af alpha-polymorfisk eletriptanhydrobromid
DK1809267T3 (da) Farmaceutiske kompositioner baseret på NK2-antagonister til pædiatrisk anvendelse
DK1594520T3 (da) Anvendelse af antagonister af bradykinin B2 receptorer til behandling af osteoarthrosis
DK1685104T3 (da) Fremgangsmåde til fremstilling af N-substituerede phthalomider
DK1506820T3 (da) Spröjteanordning